|Articles|December 1, 2017
- Pharmaceutical Executive-12-01-2017
- Volume 37
- Issue 12
Pharmaceutical Executive, December 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive December 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 8 years ago
Global Health: Fighting the Good Fightalmost 8 years ago
Global Health: Partnerships Hold the Keyalmost 8 years ago
First Foray into Digital Adherencealmost 8 years ago
Global Health: Messages of Hopealmost 8 years ago
A Year of Transformation for Science & Medicinealmost 8 years ago
Access and Reimbursement for Adoptive T-Cell Transfer Drugsalmost 8 years ago
Will Europe Turn a Corner in Personalized Medicine?almost 8 years ago
Fulfilling the Vision of Science: AstraZeneca's Ruud Dobberalmost 8 years ago
Country Report: CanadaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Sends Amended Acquisition Proposal to Metsera
2
Pharmaceutical Executive Daily: Kimberly-Clark’s $48.7 Billion Acquisition of Kenvue
3
Texas Files to Prevent Kenvue Dividend Payment
4
FDA Approves Kygevvi Becoming the First Treatment for Thymidine Kinase 2 Deficiency
5
